Abazari Azin, Abbouda Alessandro, Cruzat Andrea, Cavalcanti Bernardo, Pavan-Langston Deborah, Hamrah Pedram
Cornea Service, New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
Cornea Open. 2024 Mar;3(1). doi: 10.1097/coa.0000000000000029. Epub 2024 Mar 28.
To study potential corneal reinnervation and recovery of corneal sensation in patients with severe neurotrophic keratopathy (NK) secondary to herpes zoster ophthalmicus (HZO) after treatment with topical autologous serum tears (AST).
Four cases of HZO with severe NK were followed clinically and by serial laser confocal microscopy (IVCM, HRT3/RCM, Heidelberg Engineering) before and during treatment with 20% AST drops eight times a day. Two masked observers reviewed the IVCM images and assessed corneal nerve alterations.
At baseline, all patients had complete loss of corneal sensation. In addition, IVCM showed complete lack of the subbasal corneal nerve plexus in all patients. All four patients were refractory to conventional therapies and were treated with AST drops. All patients demonstrated significant nerve regeneration by IVCM within 3-7 months of treatment. The total nerve density increased to a mean ± SEM of 10,085.88±2,542.74 μm/mm at the last follow up. Corneal sensation measured by Cochet-Bonnet esthesiometry improved to a mean ± SEM of 3.50±1.30 cm. Interestingly, 3 of 4 patients developed stromal keratitis with ulceration within weeks of corneal reinnervation, which was reversed by adding topical steroids.
Autologous serum tears are effective in restoring corneal subbasal nerves and sensation in patients with severe NK secondary to HZO. However, this group of patients may require concurrent topical immunomodulation and antiviral therapy while on AST to prevent stromal keratitis.
研究眼部带状疱疹(HZO)继发严重神经营养性角膜病变(NK)患者局部应用自体血清泪液(AST)治疗后角膜神经再支配和角膜感觉恢复的可能性。
对4例HZO继发严重NK的患者进行临床随访,并在每天8次使用20%AST滴眼液治疗前及治疗期间,通过系列激光共聚焦显微镜检查(IVCM,HRT3/RCM,海德堡工程公司)进行观察。两名盲法观察者查看IVCM图像并评估角膜神经改变情况。
基线时,所有患者角膜感觉完全丧失。此外,IVCM显示所有患者角膜基底膜下神经丛完全缺失。所有4例患者对传统治疗均无效,接受了AST滴眼液治疗。所有患者在治疗3 - 7个月内通过IVCM显示有明显的神经再生。末次随访时,总神经密度增加至平均±标准误为10,085.88±2,542.74μm/mm。用Cochet - Bonnet触觉测量仪测得的角膜感觉改善至平均±标准误为3.50±1.30 cm。有趣的是,4例患者中有3例在角膜神经再支配数周内发生了基质性角膜炎伴溃疡,通过加用局部类固醇激素后病情逆转。
自体血清泪液对恢复HZO继发严重NK患者的角膜基底膜下神经和感觉有效。然而,该组患者在使用AST治疗期间可能需要同时进行局部免疫调节和抗病毒治疗,以预防基质性角膜炎。